Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: TechNavio (Infiniti Research Ltd.) | PRODUCT CODE: 1093726

Cover Image

PUBLISHER: TechNavio (Infiniti Research Ltd.) | PRODUCT CODE: 1093726

Global Peptide Therapeutics Market 2022-2026

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 2500
PDF (Enterprise License)
USD 4000

Add to Cart

Technavio has been monitoring the peptide therapeutics market and it is poised to grow by $ 23.36 billion during 2022-2026, accelerating at a CAGR of 12.52% during the forecast period. Our report on the peptide therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of infectious diseases, availability of favorable reimbursement policies, and drugs with extended half-lives.

The peptide therapeutics market analysis includes the route of administration segment and geographic landscape.

Technavio's peptide therapeutics market is segmented as below:

By Route of Administration

  • Parenteral
  • Oral
  • Others

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the collaborations for research and development as one of the prime reasons driving the peptide therapeutics market growth during the next few years. Also, a strong pipeline of peptide therapeutics and the advent of novel technologies will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the peptide therapeutics market covers the following areas:

  • Peptide therapeutics market sizing
  • Peptide therapeutics market forecast
  • Peptide therapeutics market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading peptide therapeutics market vendors that include Almac Group Ltd., AmbioPharm Inc., Amgen Inc., AstraZeneca Plc, Bachem AG, Bristol Myers Squibb Co., Corden Pharma International GmbH, Eli Lilly and Co., Ever Pharma, F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Ipsen Pharma, Lonza Group Ltd., Novartis AG, Novo Nordisk AS, PeptiDream Inc., Pfizer Inc., PolyPeptide Group, Sanofi, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., and Wrong pharma. Also, the peptide therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR73790

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Route of Administration

  • 5.1 Market segments
  • Exhibit 24: Chart on Route of Administration - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Route of Administration - Market share 2021-2026 (%)
  • 5.2 Comparison by Route of Administration
  • Exhibit 26: Chart on Comparison by Route of Administration
  • Exhibit 27: Data Table on Comparison by Route of Administration
  • 5.3 Parenteral - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Parenteral - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Parenteral - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Parenteral - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Parenteral - Year-over-year growth 2021-2026 (%)
  • 5.4 Oral - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Oral - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Oral - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Oral - Year-over-year growth 2021-2026 (%)
  • 5.5 Others - Market size and forecast 2021-2026
  • Exhibit 36: Chart on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibit 38: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibit 39: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • 5.6 Market opportunity by Route of Administration
  • Exhibit 40: Market opportunity by Route of Administration ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 44: Chart on Geographic comparison
  • Exhibit 45: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Germany - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.9 China - Market size and forecast 2021-2026
  • Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.10 UK - Market size and forecast 2021-2026
  • Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.11 Canada - Market size and forecast 2021-2026
  • Exhibit 78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 80: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 82: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 83: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 84: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 85: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 86: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 87: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 88: Matrix on vendor position and classification
  • 10.3 Amgen Inc.
  • Exhibit 89: Amgen Inc. - Overview
  • Exhibit 90: Amgen Inc. - Product / Service
  • Exhibit 91: Amgen Inc. - Key offerings
  • 10.4 AstraZeneca Plc
  • Exhibit 92: AstraZeneca Plc - Overview
  • Exhibit 93: AstraZeneca Plc - Product / Service
  • Exhibit 94: AstraZeneca Plc - Key news
  • Exhibit 95: AstraZeneca Plc - Key offerings
  • 10.5 Eli Lilly and Co.
  • Exhibit 96: Eli Lilly and Co. - Overview
  • Exhibit 97: Eli Lilly and Co. - Product / Service
  • Exhibit 98: Eli Lilly and Co. - Key offerings
  • 10.6 Ever Pharma
  • Exhibit 99: Ever Pharma - Overview
  • Exhibit 100: Ever Pharma - Product / Service
  • Exhibit 101: Ever Pharma - Key offerings
  • 10.7 GlaxoSmithKline Plc
  • Exhibit 102: GlaxoSmithKline Plc - Overview
  • Exhibit 103: GlaxoSmithKline Plc - Business segments
  • Exhibit 104: GlaxoSmithKline Plc - Key news
  • Exhibit 105: GlaxoSmithKline Plc - Key offerings
  • Exhibit 106: GlaxoSmithKline Plc - Segment focus
  • 10.8 Novo Nordisk AS
  • Exhibit 107: Novo Nordisk AS - Overview
  • Exhibit 108: Novo Nordisk AS - Business segments
  • Exhibit 109: Novo Nordisk AS - Key offerings
  • Exhibit 110: Novo Nordisk AS - Segment focus
  • 10.9 Pfizer Inc.
  • Exhibit 111: Pfizer Inc. - Overview
  • Exhibit 112: Pfizer Inc. - Product / Service
  • Exhibit 113: Pfizer Inc. - Key news
  • Exhibit 114: Pfizer Inc. - Key offerings
  • 10.10 Sanofi
  • Exhibit 115: Sanofi - Overview
  • Exhibit 116: Sanofi - Business segments
  • Exhibit 117: Sanofi - Key news
  • Exhibit 118: Sanofi - Key offerings
  • Exhibit 119: Sanofi - Segment focus
  • 10.11 Takeda Pharmaceutical Co. Ltd.
  • Exhibit 120: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibit 121: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibit 122: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibit 123: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • 10.12 Teva Pharmaceutical Industries Ltd.
  • Exhibit 124: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibit 125: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibit 126: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibit 127: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibit 128: Teva Pharmaceutical Industries Ltd. - Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 129: Inclusions checklist
  • Exhibit 130: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 131: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 132: Research methodology
  • Exhibit 133: Validation techniques employed for market sizing
  • Exhibit 134: Information sources
  • 11.5 List of abbreviations
  • Exhibit 135: List of abbreviations
    • health: Includes veterinary drugs (excluded from the scope of the report)
Product Code: IRTNTR73790

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Route of Administration - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Route of Administration - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Route of Administration
  • Exhibits27: Data Table on Comparison by Route of Administration
  • Exhibits28: Chart on Parenteral - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Parenteral - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Parenteral - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Parenteral - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Oral - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Oral - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Oral - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Oral - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Chart on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibits37: Data Table on Others - Market size and forecast 2021-2026 ($ million)
  • Exhibits38: Chart on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits39: Data Table on Others - Year-over-year growth 2021-2026 (%)
  • Exhibits40: Market opportunity by Route of Administration ($ million)
  • Exhibits41: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits42: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits43: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits44: Chart on Geographic comparison
  • Exhibits45: Data Table on Geographic comparison
  • Exhibits46: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits79: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits80: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits81: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits82: Market opportunity By Geographical Landscape ($ million)
  • Exhibits83: Impact of drivers and challenges in 2021 and 2026
  • Exhibits84: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits85: Overview on factors of disruption
  • Exhibits86: Impact of key risks on business
  • Exhibits87: Vendors covered
  • Exhibits88: Matrix on vendor position and classification
  • Exhibits89: Amgen Inc. - Overview
  • Exhibits90: Amgen Inc. - Product / Service
  • Exhibits91: Amgen Inc. - Key offerings
  • Exhibits92: AstraZeneca Plc - Overview
  • Exhibits93: AstraZeneca Plc - Product / Service
  • Exhibits94: AstraZeneca Plc - Key news
  • Exhibits95: AstraZeneca Plc - Key offerings
  • Exhibits96: Eli Lilly and Co. - Overview
  • Exhibits97: Eli Lilly and Co. - Product / Service
  • Exhibits98: Eli Lilly and Co. - Key offerings
  • Exhibits99: Ever Pharma - Overview
  • Exhibits100: Ever Pharma - Product / Service
  • Exhibits101: Ever Pharma - Key offerings
  • Exhibits102: GlaxoSmithKline Plc - Overview
  • Exhibits103: GlaxoSmithKline Plc - Business segments
  • Exhibits104: GlaxoSmithKline Plc - Key news
  • Exhibits105: GlaxoSmithKline Plc - Key offerings
  • Exhibits106: GlaxoSmithKline Plc - Segment focus
  • Exhibits107: Novo Nordisk AS - Overview
  • Exhibits108: Novo Nordisk AS - Business segments
  • Exhibits109: Novo Nordisk AS - Key offerings
  • Exhibits110: Novo Nordisk AS - Segment focus
  • Exhibits111: Pfizer Inc. - Overview
  • Exhibits112: Pfizer Inc. - Product / Service
  • Exhibits113: Pfizer Inc. - Key news
  • Exhibits114: Pfizer Inc. - Key offerings
  • Exhibits115: Sanofi - Overview
  • Exhibits116: Sanofi - Business segments
  • Exhibits117: Sanofi - Key news
  • Exhibits118: Sanofi - Key offerings
  • Exhibits119: Sanofi - Segment focus
  • Exhibits120: Takeda Pharmaceutical Co. Ltd. - Overview
  • Exhibits121: Takeda Pharmaceutical Co. Ltd. - Product / Service
  • Exhibits122: Takeda Pharmaceutical Co. Ltd. - Key news
  • Exhibits123: Takeda Pharmaceutical Co. Ltd. - Key offerings
  • Exhibits124: Teva Pharmaceutical Industries Ltd. - Overview
  • Exhibits125: Teva Pharmaceutical Industries Ltd. - Business segments
  • Exhibits126: Teva Pharmaceutical Industries Ltd. - Key news
  • Exhibits127: Teva Pharmaceutical Industries Ltd. - Key offerings
  • Exhibits128: Teva Pharmaceutical Industries Ltd. - Segment focus
  • Exhibits129: Inclusions checklist
  • Exhibits130: Exclusions checklist
  • Exhibits131: Currency conversion rates for US$
  • Exhibits132: Research methodology
  • Exhibits133: Validation techniques employed for market sizing
  • Exhibits134: Information sources
  • Exhibits135: List of abbreviations
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!